DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20214503

Study on drug use pattern in the management of the cardiovascular diseases and with comorbidities

Mutharasan M., Manikkannan M., Pachayappan K., Veeramani G., Paari N.

Abstract


Background: Cardiovascular drugs are the number one cause of death globally; more people die annually from CVDs then from any other cause CVD. The purpose of this study to identify the rationality of drug prescribed for cardiovascular diseases with its comorbidities. Along with medication adherence and cost analysis. To assess the drug use pattern and to observe the drug related complications in patients with cardiovascular diseases.

Methods: A hospital based prospective observational study was conducted at department of medicine in RMMCH. A total of 79 patients were enrolled based on inclusion criteria and the data was collected using designed data collection form.

Results: Data of 79 patients were collected over 6 months mean age of patients with 19.95-60.5. Male to female ratio was 1.43:1. In cardiovascular diseases, most common disease conditions are systemic hypertension and acute coronary syndrome seen in our study population. Average drugs prescribed per patient was 4-9. Most frequently prescribed drug classes were beta blocker, antiplatelet, hypolipidemic agent. In these few minor drug interactions have been found. Study has no adverse drug reaction. The average cost of drugs was prescribed for 2500-3200 IND. Before patient counseling medication adherence and outcomes were less after counseling, medication adherence and outcomes are increased from 5% to 65%.

Conclusions: The study concludes that most of the drugs were prescribed rationally according to world health organization/ESC guidelines. As behalf of this study, we could provide the information about the risk factor, leading commodities. Importance of medication adherence and cost of medications to cardiovascular drugs.


Keywords


Systemic hypertension, Acute coronary syndrome, Diabetes mellitus, Medication adherence, Drug utilization cost of medication

Full Text:

PDF

References


WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2018. Oslo, Norway. 2017. Available at: https://www.whocc.no/atc_ddd_index_and_guidelines/guidelines.

WHO policy perspectives in medicines. Promoting rational use of medicines: World Health Organization. 2002. Available at: https://www.who.int/activities/promoting-rational-use-of-medicines.

WHO. Essential Medicines and Health Products Information. 2014. Available at: https://www.who.int/southeastasia/health-topics/essential-medicines.

Meena DK, Jayanthi M. Drug utilization research: a review. Int J Basic Clin Pharmacol. 2019; 8(2):354

Gupta AK, Mishra S. Prescription audit study in a tertiary care hospital using the anatomical Therapeutic chemical and defined daily dose classification concept. Int J Basic Clin Pharmacol. 2014;3:889-901.

Shah RB, Gajjar BM, Desai SV. Drug utilization pattern among geriatric patients assessed with the anatomical therapeutic chemical classification / defined daily dose system in a rural tertiary care teaching hospital. Int J Nutr Pharmacol Neurol Dis. 2012;2:258-65.

Prakash RS, Anuradha MG, Prakruti PA. Study of Drug Utilization Pattern According to Daily Define Dose in Intensive Care Unit (ICU) at Tertiary Care Teaching Hospital. Indiayp. 2015.4.9

Truter I. A review of drug utilization studies and methodologies. Jordan J Pharmaceut Sci. 2008;1(2):91-103.

Shewade DG, Pradhan SC. Auditing of prescriptions in Government teaching hospital and four retail medical stores in Pondicherry. Ind J Pharmacol. 1998;30:408-10.

Shenoy S, Rao J, Sen A, Kumar V. Evaluation of the drug-prescribing pattern in elderly patients in tertiary care hospital. Ind J Pharmacol. 2006;38(1):90.

Uppal R. Utilization of antimicrobials for caesarean section in a district hospital in India. Apua Newsl. 1990;8:2.

Uppal R. Antimicrobial drug usage in urology. Int J Clin Pharmacol Ther Toxiocol. 1991;29(a):336-8.

Duke MNG. Drug Utilization Studies-Method and Uses. European Series No. 45. Copenhagen, Denmark: WHO Regional Publications. 1993;1-4.

Ramsay LE. Bridging the gap between clinical pharmacology and rational drug prescribing. Br J Clin Pharmacol. 1993;35(6):575-6.

Gupta N, Sharma D, Garg SK, Bhargava VK. Auditing of prescriptions to study utilization of antimicrobials in a tertiary hospital. Indian J Pharmacol. 1997;29(6):411-15

Benet LZ. Principles of prescription order writing and patients compliance instructions. In: Goodman AG, Rail TW, Nies AS, Taylor P, editors. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 8th edition. New York: Pegamon Press Inc. 1991;1640.

Shrishlya MV, Mahesh K, Nagarani MA, Sr Mary C, Andrade C, Venkataraman BV. Prescription audit study in an Indian hospital setting using the DDD (defined daily dose). Concept. Indian J Pharmacol. 1994;26(1):23-8.

Wettermark B, Almarsdóttir AB, Andersen M, Benko R, Bennie M et al. Drug Utilization Research: Methods and Applications, First Edition. Elsevier’s M, eds. John Wiley and Sons Ltd; 2016.

WHO Collaborating Centre for Drug Statistics Methodology. Available at: https://www.whocc.no/atc_ddd_index.

Revikumar KG. Pharmacoepidemiology and Pharmacoeconomics Concepts and Practice. PharmaMed Press/BSP Books. 2016.